Market evolution: Orthopaedic braces (CN 90211010) — 2015–2025

Introduction

This report analyses the evolution of EU trade in orthopaedic appliances (customs code 90211010) over the period 2015–2025. The product category covers orthopaedic or fracture appliances, including splints and similar devices. The EU has been a significant participant in this market as both an importer and an exporter, and the decade examined here reveals a number of structural shifts: strong value growth on both the import and export sides, a dramatic expansion in import volumes (particularly from emerging suppliers), rising domestic production, and a notable increase in the EU's net import reliance. The full overview data underpinning these observations is presented below.

1. Value Growth Outpaces Volume, Revealing a Premiumisation Trend

EU exports grew strongly in value but only modestly in volume

Between 2015 and 2025, EU exports of orthopaedic appliances rose from €596.96 million to €927.94 million, an increase of +55.4% in value. Over the same period, export volume grew from 3,770.8 tonnes to 3,979.8 tonnes — a mere +5.5%. The unit price of EU exports climbed from approximately €158,284 per tonne to €232,987 per tonne (+47.2%). This divergence indicates that the EU is increasingly exporting higher-value-added orthopaedic products — a pattern consistent with specialisation in technologically sophisticated medical devices rather than commodity-grade goods. The trade dashboard confirms this value-volume gap.

Import volumes surged while unit prices fell

EU imports tell a contrasting story. Import value rose from €883.65 million to €1,221.92 million (+38.3%), but import volumes expanded far more dramatically — from 16,303.3 tonnes to 26,293.5 tonnes (+61.3%). Consequently, the average import price declined from €54,191 per tonne to €46,470 per tonne (−14.2%). This suggests a shift in the composition of imports toward lower-cost suppliers and/or product lines, potentially reflecting the growing role of Asian and Latin American manufacturers offering competitive pricing.

The trade deficit remained structurally persistent

The EU has run a trade deficit in orthopaedic appliances throughout the entire period, moving from −€286.69 million in 2015 to −€293.98 million in 2025 (−2.5% change). However, this headline stability masks significant volatility: the deficit widened to as much as −€863.41 million at its peak before narrowing back. The near-constant final balance, despite both exports and imports growing substantially, reflects the offsetting effect of rising export unit values compensating for surging import volumes.

2. Shifting Partners and the Rise of Mexico and China as Import Suppliers

The United States remained the EU's top import source, but its share eroded

The United States was the EU's largest single source of orthopaedic imports at the start and end of the period, with import values of €311.68 million (2015) and €294.48 million (2025), a slight decline of −5.5%. While still dominant, the US share of EU imports has been diluted by the rapid growth of other suppliers. The partner data shows the shifting composition clearly.

Mexico emerged as a major and highly volatile import source

The most striking structural change on the import side is the explosive growth of Mexican exports to the EU. Imports from Mexico surged from €98.63 million to €373.09 million (+278.3%), making Mexico the second-largest supplier by 2025 — and at times even the largest, with a peak of €783.48 million in an intermediate year. This growth is accompanied by very high volatility (coefficient of variation of 0.49, the highest among the top import partners), suggesting that flows are driven by a relatively small number of large transactions or firms, and may reflect the positioning of global medical-device manufacturers using Mexico as an export platform.

China's import presence more than tripled

Imports from China grew from €64.74 million to €235.12 million (+263.2%), positioning China as the third-largest supplier. This aligns with the broader pattern of China expanding its medical-device exports to the EU. The growth is more gradual than Mexico's, suggesting a steadier but equally significant structural shift.

EU export geography is diversifying, with the UK as the fastest-growing destination

On the export side, the United States remained the top EU export destination (€145.83M → €161.11M, +10.5%), but the United Kingdom saw the most dramatic growth: from €120.41 million to €214.60 million (+78.2%). This likely reflects post-Brexit trade reorientation, where UK-based buyers increasingly source from the EU as a separate customs territory. Switzerland also grew notably (€56.82M → €86.36M, +52.0%). Meanwhile, exports to Tunisia declined (−32.2%). The export partner data confirms this diversification.

EU domestic production more than doubled

According to PRODCOM data, EU production of orthopaedic appliances grew from approximately €1,601 million to €3,500 million (+118.6%) over the period. This substantial increase suggests that the EU's orthopaedic device industry expanded significantly, even as import volumes surged. The coexistence of rising production and rising imports points to growing overall demand — driven by ageing populations, rising healthcare expenditure, and increased sports medicine needs — rather than a simple substitution of domestic production by imports.

3. Rising Vulnerability Amid Geographical Concentration and Price Shocks

Net import reliance increased sharply

Perhaps the most policy-relevant finding is the dramatic rise in the EU's net import reliance, which climbed from 1.6% in 2015 to 16.6% in 2025 — a +954.4% change. At its peak, net import reliance reached 29.7%. This metric, which measures the extent to which domestic consumption depends on net imports, indicates a growing structural dependence on external supply for orthopaedic devices. While the EU's export base has also grown (export propensity rose from 28.1% to 48.9%), the faster growth of imports means the EU has become a net absorber of foreign orthopaedic products.

Import concentration declined but remains moderate

The Herfindahl-Hirschman Index (HHI) for import value fell from 2,291 to 2,025 (−11.6%), indicating modest diversification away from a small number of dominant suppliers. However, this level still implies a moderately concentrated import structure, with the US, Mexico, and China collectively accounting for a very large share. Export concentration also fell slightly (HHI from 1,197 to 1,142, −4.6%), suggesting the EU's export markets are already relatively diversified and became marginally more so.

Significant price shocks were detected in key trade flows

The volatility analysis identified three notable price shocks:

The 2018 US export price shock is particularly noteworthy given the United States' large share of EU exports (27.4% of value). A 47.7% price spike in such a significant market may reflect currency movements, tariff-related repricing (the US imposed tariffs on certain EU goods in this period), or shifts in product mix. The Algeria shock, while dramatic in percentage terms (+308.8%), affected a small share of total trade and may reflect a low-volume baseline. Tunisia was the most volatile EU export partner overall (CV of 0.85), followed by Algeria (CV of 0.51), indicating that flows to North Africa are inherently unstable.

Ireland and Poland emerged as specialised EU producers

Looking at revealed comparative advantage within the EU, Ireland (RSCA: 0.73, RCA: 6.28) and Poland (RSCA: 0.43, RCA: 2.51) are the most specialised EU Member States in orthopaedic appliances as of 2025. Poland's emergence is especially remarkable: its exports grew from €1.59 million in 2015 to €203.60 million in 2025 (+12,736%), and its imports similarly surged from €6.19 million to €43.71 million (+605.8%). Ireland's exports grew from €9.89 million to €91.85 million (+828.4%). Both countries appear to be building or attracting significant orthopaedic manufacturing capacity. By contrast, Latvia, Slovakia, Luxembourg, Hungary, and Cyprus show minimal specialisation (negative RSCA values), consistent with a geographically concentrated production base within the EU.

Conclusion

The EU market for orthopaedic appliances (CN 90211010) experienced robust growth between 2015 and 2025, with both trade values and domestic production rising substantially. However, the nature of this growth differed markedly between exports and imports. EU exports became increasingly premium-priced, suggesting a focus on high-end, technology-intensive orthopaedic devices. Import volumes, meanwhile, grew even faster, driven primarily by surging supply from Mexico and China at lower unit prices — pointing to a growing role for cost-competitive foreign manufacturers in meeting EU demand.

This dynamic has led to a significant increase in the EU's net import reliance, rising from near self-sufficiency (1.6%) to a meaningful dependence on external supply (16.6%). While import sources have diversified somewhat (the HHI fell by 11.6%), the concentration of imports among a small number of countries — the US, Mexico, and China — creates potential vulnerability, particularly given the high volatility observed in flows from Mexico and the price shocks detected in key export markets.

On a more positive note, the EU's domestic production base expanded significantly (+118.6% in value), and new centres of specialisation are emerging within the EU, notably in Poland and Ireland. The overall picture is one of a growing, increasingly globalised market in which the EU retains a strong position as a high-value exporter, but faces rising import competition and growing strategic dependence on a limited number of external suppliers.